Table of Contents

company-logo

BerGenBio ASA, a clinical-stage biopharmaceutical company, engages in development of drugs to treat immune evasive, drug resistant, and metastatic cancers; and respiratory diseases. Its lead candidate is Bemcentinib, a bio-available small molecule AXL inhibitor, which is in Phase II clinical development in major cancer indications and COVID-19. Its Phase II clinical trial program focuses on treatment of non-small cell lung cancer, acute myeloid leukaemia, and myelodysplastic syndrome, as well as COVID-19. In addition, it is developing tilvestamab, an anti-AXL antibody that is in Phase Ib clinical trial. BerGenBio ASA has a collaboration agreement with Merck & Co. for clinical trials. The company was incorporated in 2007 and is based in Bergen, Norway.

BerGenBio Dividend Announcement

• BerGenBio does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on BerGenBio dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

BerGenBio Dividend History

BerGenBio Dividend Yield

BerGenBio current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing BerGenBio stock? Use our calculator to estimate your expected dividend yield:

BerGenBio Financial Ratios

P/E ratio-3.26
PEG ratio-0.03
P/B ratio3.24
ROE-110.87%
Payout ratio0.00%
Current ratio4.71
Quick ratio4.71
Cash Ratio4.23

BerGenBio Dividend FAQ

Does BerGenBio stock pay dividends?
BerGenBio does not currently pay dividends to its shareholders.
Has BerGenBio ever paid a dividend?
No, BerGenBio has no a history of paying dividends to its shareholders. BerGenBio is not known for its dividend payments.
Why doesn't BerGenBio pay dividends?
There are several potential reasons why BerGenBio would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will BerGenBio ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While BerGenBio has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is BerGenBio a dividend aristocrat?
BerGenBio is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is BerGenBio a dividend king?
BerGenBio is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is BerGenBio a dividend stock?
No, BerGenBio is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy BerGenBio stocks?
To buy BerGenBio you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy BerGenBio stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.